145 related articles for article (PubMed ID: 37113722)
21. Use of bioimpedance spectroscopy for prospective surveillance and early diagnosis of breast cancer-related lymphedema.
Forte AJ; Huayllani MT; Boczar D; Avila FR; Kassis S; Ciudad P; Lu X; Moore PA; McLaughlin SA
Breast Dis; 2021; 40(2):85-93. PubMed ID: 33646139
[TBL] [Abstract][Full Text] [Related]
22. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
[TBL] [Abstract][Full Text] [Related]
23. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
Vicini F; Shah C; Whitworth P; Walker M; Shi J
Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
[No Abstract] [Full Text] [Related]
24. Bioimpedance Spectroscopy for Breast Cancer Related Lymphedema Assessment: Clinical Practice Guidelines.
Shah C; Vicini FA; Arthur D
Breast J; 2016 Nov; 22(6):645-650. PubMed ID: 27487985
[TBL] [Abstract][Full Text] [Related]
25. Early Disturbance of Lymphatic Transport as a Risk Factor for the Development of Breast-Cancer-Related Lymphedema.
Thomis S; Devoogdt N; Bechter-Hugl B; Fourneau I
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980660
[TBL] [Abstract][Full Text] [Related]
26. Screening for Breast Cancer-Related Lymphedema Development Using Extracellular Water Ratio.
Yasunaga Y; Kinjo Y; Kondoh S; Yanagisawa D; Yuzuriha S; Kondoh S
Lymphat Res Biol; 2023 Oct; 21(5):447-455. PubMed ID: 36951667
[No Abstract] [Full Text] [Related]
27. Assessment of segmental arm soft tissue composition in breast cancer-related lymphedema: a pilot study using dual energy X-ray absorptiometry and bioimpedance spectroscopy.
Czerniec SA; Ward LC; Meerkin JD; Kilbreath SL
Lymphat Res Biol; 2015 Mar; 13(1):33-9. PubMed ID: 25668060
[TBL] [Abstract][Full Text] [Related]
28. EFFECTS OF COMPRESSION ON LYMPHEDEMA DURING RESISTANCE EXERCISE IN WOMEN WITH BREAST CANCER-RELATED LYMPHEDEMA: A RANDOMIZED, CROSS-OVER TRIAL.
Singh B; Newton RU; Cormie P; Galvao DA; Cornish B; Reul-Hirche H; Smith C; Nosaka K; Hayes SC
Lymphology; 2015 Jun; 48(2):80-92. PubMed ID: 26714372
[TBL] [Abstract][Full Text] [Related]
29. Comparison Between the Effectiveness of Complex Decongestive Therapy and Stellate Ganglion Block in Patients with Breast Cancer-Related Lymphedema: A Randomized Controlled Study.
Park MW; Lee SU; Kwon S; Seo KS
Pain Physician; 2019 May; 22(3):255-263. PubMed ID: 31151333
[TBL] [Abstract][Full Text] [Related]
30. Bioimpedance spectroscopy is not associated with a clinical diagnosis of breast cancer-related lymphedema.
Spitz JA; Chao AH; Peterson DM; Subramaniam V; Prakash S; Skoracki RJ
Lymphology; 2019; 52(3):134-142. PubMed ID: 31874125
[TBL] [Abstract][Full Text] [Related]
31. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer - a long-term observation.
Rupp J; Hadamitzky C; Henkenberens C; Christiansen H; Steinmann D; Bruns F
Radiat Oncol; 2019 Mar; 14(1):39. PubMed ID: 30845971
[TBL] [Abstract][Full Text] [Related]
32. Implementation of Single-Tab Electrodes for Bioimpedance Spectroscopy Measures.
Donahue PMC; Crescenzi R; Du L; Donahue MJ
Lymphat Res Biol; 2020 Jun; 18(3):277-283. PubMed ID: 31536441
[No Abstract] [Full Text] [Related]
33. A novel, validated method to quantify breast cancer-related lymphedema (BCRL) following bilateral breast surgery.
Miller CL; Specht MC; Horick N; Skolny MN; Jammallo LS; O'Toole J; Taghian AG
Lymphology; 2013 Jun; 46(2):64-74. PubMed ID: 24354105
[TBL] [Abstract][Full Text] [Related]
34. Current Diagnostic Tools for Breast Cancer-Related Lymphedema.
Shah C; Asha W; Vicini F
Curr Oncol Rep; 2023 Mar; 25(3):151-154. PubMed ID: 36696076
[TBL] [Abstract][Full Text] [Related]
35. Bilateral Changes in Deep Tissue Environment After Manual Lymphatic Drainage in Patients with Breast Cancer Treatment-Related Lymphedema.
Donahue PM; Crescenzi R; Scott AO; Braxton V; Desai A; Smith SA; Jordi J; Meszoely IM; Grau AM; Kauffmann RM; Sweeting RS; Spotanski K; Ridner SH; Donahue MJ
Lymphat Res Biol; 2017 Mar; 15(1):45-56. PubMed ID: 28323572
[TBL] [Abstract][Full Text] [Related]
36. Segmental limb volume change as a predictor of the onset of lymphedema in women with early breast cancer.
Stout NL; Pfalzer LA; Levy E; McGarvey C; Springer B; Gerber LH; Soballe P
PM R; 2011 Dec; 3(12):1098-1105. PubMed ID: 21974905
[TBL] [Abstract][Full Text] [Related]
37. Bioimpedance Spectroscopy for Assessment of Breast Cancer-Related Lymphedema: A Systematic Review.
Forte AJ; Huayllani MT; Boczar D; Ciudad P; Lu X; Kassis S; Parker AS; Moore PA; McLaughlin SA
Plast Surg Nurs; 2020; 40(2):86-90. PubMed ID: 32459756
[TBL] [Abstract][Full Text] [Related]
38. Experimental and Analytical Comparisons of Tissue Dielectric Constant (TDC) and Bioimpedance Spectroscopy (BIS) in Assessment of Early Arm Lymphedema in Breast Cancer Patients after Axillary Surgery and Radiotherapy.
Lahtinen T; Seppälä J; Viren T; Johansson K
Lymphat Res Biol; 2015 Sep; 13(3):176-85. PubMed ID: 26305554
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Volume Measurements and Bioimpedance Spectroscopy Using A Stand-on Device for Assessment of Unilateral Breast Cancer-Related Lymphedema.
Ward LC; Thompson B; Gaitatzis K; Koelmeyer LA
Eur J Breast Health; 2024 Apr; 20(2):141-148. PubMed ID: 38571690
[TBL] [Abstract][Full Text] [Related]
40. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]